|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-08
|
$704,474
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes
|
1R01CA216265-01
|
$632,860
|
CHRISTENSEN, BROCK
|
DARTMOUTH COLLEGE
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
402 -- A PHASE I TRIAL OF THE SAFETY IMMUNOGENICITY OF RG1-VLP... (PROTOCOL UWI2016-08-02). CONTRACTOR: UNIVERSITY OF WISCONSIN. CONTRACT NO: HHSN261201200033I, TASK ORDER: HHSN261000012. FROM 9/1
|
261201200033I
|
$1,485,915
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
2U01CA164974-07
|
$2,195,369
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-06
|
$639,740
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$339,315
|
Barchi, Joseph
|
CCR (NCI)
|
|
A Novel Mouse Model for Uterine Leiomyoma
|
1R03CA219326-01
|
$80,000
|
WONG, KWONG KWOK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
A Phase I Combination Study of Durvalumab and Vicinium in BCG refractory NMIBC
|
ZIA BC 011786
|
$32,548
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A pooled analysis of dietary long-chain omega-3 fatty acid intake and endometrial cancer risk
|
1R03CA212808-01A1
|
$77,542
|
BRASKY, THEODORE
|
OHIO STATE UNIVERSITY
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$97,645
|
Agarwal, Piyush
|
CCR (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$703,174
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$703,174
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
5U24CA180921-05
|
$705,863
|
BECICH, MICHAEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Analyzing Complex Cancer Studies With Skewed Responses
|
5R03CA205018-02
|
$83,299
|
LIPSITZ, STUART
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
Barr, Frederic
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
Barr, Frederic
|
CCR (NCI)
|
|
Assessment of Screening Modalities for Gynecologic Cancers
|
ZIA CP010126-10495
|
$126
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,161,432
|
N/A
|
DCEG (NCI)
|
|
Bayesian methods for complex, high-dimensional functional data in cancer research
|
5R01CA178744-03
|
$358,240
|
MORRIS, JEFFREY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
BCDDP: Breast cancer detection demonstration project followup study - I
|
ZIA CP010182-01030
|
$41,204
|
Schairer, Catherine
|
DCEG (NCI)
|
|
BCG therapy of bladder cancer: the role of BCG uptake by bladder cancer cells
|
5K08CA184038-04
|
$177,660
|
REDELMAN-SIDI, GIL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Behavioral Economics and Improving Chemotherapy Decisions for Advanced Cancer
|
5K24CA181510-04
|
$172,242
|
KEATING, NANCY
|
HARVARD MEDICAL SCHOOL
|
|
Biomarkers for Staging and Treatment Response Monitoring of Bladder Cancer
|
5U01CA179106-04
|
$548,074
|
HADJIYSKI, LUBOMIR
|
UNIVERSITY OF MICHIGAN
|
|
Bladder Cancer GWAS
|
ZIA CP010187-10461
|
$22,955
|
Rothman, Nat
|
DCEG (NCI)
|
|
Bladder cancer in the Northeastern U.S.
|
ZIA CP010125-02212
|
$409,947
|
Silverman, Debra
|
DCEG (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$357,695
|
Apolo, Andrea
|
CCR (NCI)
|
|
Building sustainable and innovative research in Cancer and Cardiovascular disease: Planning the design and development of the South American Center of Research Excellence to Counter NCDs (SACREN)
|
1P20CA217231-01
|
$249,500
|
Irazola, Vilma
|
INSTITUTO DE EFECTIVIDAD CLINICA Y SANIT
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-04
|
$519,002
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-04
|
$519,002
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Cancer Cell Mechanical Profiling Analysis
|
1R21CA208196-01A1
|
$168,744
|
RAO, JIANYU
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S1
|
$123,768
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S1
|
$123,768
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S2
|
$75,000
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S2
|
$75,000
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S3
|
$120,000
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S3
|
$120,000
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|